de Mello AH, Schraiber RB, Goldim MPS, Garcez ML, Gomes ML, de Bem Silveira G, Zaccaron RP, Schuck PF, Budni J, Silveira PCL, Petronilho F, Rezin GT (2019) Omega-3 fatty acids attenuate brain alterations in High-Fat Diet-Induced obesity model
Significant results In clinic trials, individuals using once weekly Semaglutide lost an average of 15% of their body weight, with 1 in 3 patients losing 20%+ in 68 weeks
To enhance the reliability of our findings, we analyzed the primary outcome starting one month after the index date
This medication is taken once per week as part of a clinical weight management program, which may help individuals achieve their health and weight goals